San Francisco-based healthcare company Viz.AI received FDA marketing authorization for its stroke care ContactCT application.

The software device provides clinical decision support using deep learning algorithms to automatically analyze CT neuro images for the detection of indicators associated with stroke.

It also notifies clinicians when a potential stroke is identified in their patients, enabling direct-to-intervention care. The company obtained CE Marking for ContactCT just last month.